Literature DB >> 18675456

The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta.

Y Seval1, L Sati, C Celik-Ozenci, O Taskin, R Demir.   

Abstract

Angiopoietins are integral to vasculogenesis and angiogenesis, which play crucial roles in the growth and development of the placenta. The current study assessed expression of angiopoietins (Ang-1 and Ang-2) and their receptors (Tie-1 and Tie-2) during development of the early human placenta. First-trimester placental tissues were obtained from women undergoing curettage during normal pregnancies. The use of immunohistochemistry (IHC) showed that Ang-1 was primarily localized to syncytiotrophoblasts where it displayed moderate immunoreactivity, whereas weak immunoreactivity for Ang-1 was observed in endothelial cells and angiogenic cell cords (ACC). Strong immunoreactivity for Ang-2 was also found predominantly in syncytiotrophoblasts with lower immunostaining levels evident in cytotrophoblasts. Moderate immunoreactivity for Ang-2 was observed in endothelial cells, ACC and Hofbauer cells. By contrast, the trophoblastic shell, as well as endothelial cells and ACC exhibited strong staining intensity for Tie-1 with the strongest immunoreactivity for Tie-2 observed in cytotrophoblasts, ACC and endothelial cells. Western blotting of tissue extracts confirmed the IHC results. Previous studies focused on VEGF and its receptors in controlling vasculogenesis and angiogenesis in human placenta. However, the specific localization patterns of angiopoietins and their receptors revealed by the current study emphasize the importance of these molecules in placental vascular development. Functional studies aimed at identifying the molecular mechanisms of actions of these factors and receptors may prove essential in elucidating the pathophysiology of placental disorders such as intrauterine growth restriction and pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675456     DOI: 10.1016/j.placenta.2008.06.009

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  15 in total

1.  The first trimester human placenta is a site for terminal maturation of primitive erythroid cells.

Authors:  Ben Van Handel; Sacha L Prashad; Nargess Hassanzadeh-Kiabi; Andy Huang; Mattias Magnusson; Boriana Atanassova; Angela Chen; Eija I Hamalainen; Hanna K A Mikkola
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

Review 2.  Angiogenic factors in preeclampsia and related disorders.

Authors:  Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

3.  Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

Authors:  Dorien Reijnders; Chin-Chi Liu; Xinjing Xu; Anna M Zhao; Kelsey N Olson; Scott D Butler; Nataki C Douglas; Jenny L Sones
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

Review 4.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

5.  Dysregulation of promyelocytic leukemia (PML) protein expression in preeclamptic placentae.

Authors:  Jonathan D Leavenworth; Kathleen A Groesch; Scott Malm; Ronald J Torry; Robert Abrams; Donald S Torry
Journal:  Reprod Sci       Date:  2010-04       Impact factor: 3.060

6.  Dysregulation of angiopoietins is associated with placental malaria and low birth weight.

Authors:  Karlee L Silver; Kathleen Zhong; Rose G F Leke; Diane Wallace Taylor; Kevin C Kain
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

Review 7.  The paracrinology of tubal ectopic pregnancy.

Authors:  Julie L V Shaw; Andrew W Horne
Journal:  Mol Cell Endocrinol       Date:  2011-07-30       Impact factor: 4.102

8.  High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes.

Authors:  C-L Cheng; H-A Hou; J-Y Jhuang; C-W Lin; C-Y Chen; J-L Tang; W-C Chou; M-H Tseng; M Yao; S-Y Huang; B-S Ko; S-C Hsu; S-J Wu; W Tsay; Y-C Chen; H-F Tien
Journal:  Br J Cancer       Date:  2011-08-30       Impact factor: 7.640

9.  Role of the angiopoietin/Tie system in pregnancy (Review).

Authors:  D Kappou; S Sifakis; A Konstantinidou; N Papantoniou; D A Spandidos
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

10.  Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.

Authors:  Maofeng Wang; Junqing Chen; Jun Ying; Jiong Yu; Bifei Huang; Zhaoxiang Ren; Xianyu Wang; Qiaoqiao Guo; Yunlai Wang; Liuyi Qiu; Hongsheng Yu; Rugen Wan
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.